Manipal Health Enterprises Ltd, a healthcare giant listing on BSE and NSE, has unveiled key details for its upcoming mainboard IPO. Here’s what retail investors need to know:
This structure means that retail investors must apply for at least 25 shares, representing a minimum investment of ₹14,750 (25 × ₹590, the upper band).
Manipal Health Enterprises is one of India’s largest integrated multispecialty hospital networks, operating a pan‑India chain that offers tertiary and quaternary care across specialties including cardiac sciences, oncology, neurosciences, gastro sciences, orthopaedics, and renal sciences. It stands out as the largest hospital network by bed capacity in India ([sebi.gov.in](https://www.sebi.gov.in/sebi_data/commondocs/apr-2026/Manipal%20Health%20Enterprises%20Limited-Abridged%20Prospectus_p.pdf?utm_source=openai)).
Recent strategic moves underline its expansion momentum. Notably, the company acquired a hospital property in Mumbai’s Andheri for ₹495 crore, consolidating its footprint in a key market and highlighting investor confidence ahead of its IPO ([hindustantimes.com](https://www.hindustantimes.com/real-estate/manipal-health-enterprises-buys-752-sq-m-land-parcel-with-hospital-building-in-mumbai-s-andheri-for-495-crore-101778508824431.html/?utm_source=openai)). It has also secured long-term leases in Bengaluru, including a nearly 30-year agreement with a rental commitment exceeding ₹800 crore ([economictimes.indiatimes.com](https://economictimes.indiatimes.com/topic/manipal-health-enterprises?utm_source=openai)).
Stay tuned for the allotment status and listing price once the IPO subscription process concludes on 31 July 2026.